Viking Therapeutics (Warrant)

YTD

ALL

Why Robinhood?

You can watch VKTXW and buy or sell other stocks, options, and ETFs commission-free!

About VKTXW

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.

CEO

Brian Lian, PhD, MBA

CEOBrian Lian, PhD, MBA

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

—

Employees—

VKTXW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

VKTXW News

Seeking Alpha 12h

Viking Therapeutics, Inc. Q1 2024 Earnings Call Transcript - Seeking Alpha

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 EarninConference Call April 24, 2024 8:30 AM ET Company Participants Stephanie Diaz - Manager, Investor Relati...

Benzinga 15h

Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO

Loading... Loading... Viking Therapeutics, Inc. VKTX reported its first-quarter financial results after the bell Wednesday. Here's a look at the highlights. T...

Benzinga 3d

Looking At Viking Therapeutics's Recent Unusual Options Activity - Viking Therapeutics - Benzinga

Loading... Loading... Deep-pocketed investors have adopted a bullish approach towards Viking Therapeutics VKTX, and it's something market players shouldn't ign...

More VKTXW News

Yahoo Finance 6d

Viking Therapeutics, Inc. Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance

Viking Therapeutics, Inc. (VKTX) ended the recent trading session at $63.42, demonstrating a -1.93% swing from the preceding day's closing price. This change la...

Seeking Alpha 7d

Viking Therapeutics: An Oral Weight Loss Drug With More Data Ahead - Seeking Alpha

Xavier Lorenzo/iStock via Getty Images Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing VK2735 for obesity, among other drugs in its pipeline, and has rep...